<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00890630</url>
  </required_header>
  <id_info>
    <org_study_id>09-3265</org_study_id>
    <nct_id>NCT00890630</nct_id>
  </id_info>
  <brief_title>Intracervical Catheters for Induction of Labour in Women With Prelabour Rupture of Membranes at Term</brief_title>
  <acronym>IC-PROM</acronym>
  <official_title>Intracervical Catheters for Induction of Labour in Women With Prelabour Rupture of Membranes at Term: A Pilot Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Joseph's Healthcare Hamilton</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the feasibility of using intracervical balloon
      catheters for cervical ripening as part of labour induction in healthy, GBS-negative women
      with prelabour rupture of membranes at term.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized controlled trial comparing two methods of induction of labour for
      pregnant, GBS-negative women presenting with prelabour rupture of membranes at term.

      The intervention consists of the insertion of a double-balloon intracervical catheter at the
      time of induction, followed immediately by oxytocin infusion. The control consists of
      standard therapy: oxytocin induction. Our primary outcome is feasibility, and our secondary
      outcomes are length of first and second stages of labour, rate of vaginal delivery,
      intrapartum fever, chorioamnionitis, NICU admission, suspected or proven neonatal sepsis, or
      serious neonatal complication.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Inadequate Patient Recruitment.
  </why_stopped>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intrapartum Fever</measure>
    <time_frame>48 Hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Labour</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NICU Admission</measure>
    <time_frame>0-7 days postpartum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chorioamnionitis</measure>
    <time_frame>48 Hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>0-6 weeks Postpartum</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Fetal Membranes, Premature Rupture</condition>
  <condition>Induced Labor</condition>
  <arm_group>
    <arm_group_label>Oxytocin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Induction of Labour with Oxytocin Alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intracervical Catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Insertion of an Intracervical Balloon Catheter plus administration of oxytocin for labour induction.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intracervical Balloon Catheter</intervention_name>
    <description>Intracervical insertion of an 80cc Double-Balloon Catheter.</description>
    <arm_group_label>Intracervical Catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxytocin</intervention_name>
    <description>IV Oxytocin infusion, dose dependent on patient response. Start at 2mIU/min, increasing every 30 minutes by 2mIU/min, to max 24mIU/min.</description>
    <arm_group_label>Oxytocin</arm_group_label>
    <arm_group_label>Intracervical Catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton Pregnancy

          -  37.0 and 41.0 gestational age

          -  Confirmed Rupture of Membranes

          -  Group B Streptococcus Negative

          -  Cephalic Presentation

          -  Absence of contractions for at least 60 minutes following rupture

          -  Absence of contractions at time of enrolment

        Exclusion Criteria:

          -  Contraindication to Vaginal Delivery

          -  Previous Uterine Surgery, including Caesarean Section

          -  Previous Cerclage, Cone Biopsy, LEEP, or Cervical Surgery

          -  Documented history of cervical incompetence

          -  High Grade intraepithelial lesion, adenocarcinoma in situ, or invasive cervical
             cancer.

          -  Immunosuppressed State

          -  Active Vaginal Infection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dustin Costescu, MD, BSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University, Department of Obstetrics and Gynaecology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amie Cullimore, MD BSc BEd</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University, Department of Obstetrics and Gynaecology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St Joseph's Healthcare Hamilton</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2009</study_first_submitted>
  <study_first_submitted_qc>April 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2009</study_first_posted>
  <last_update_submitted>July 19, 2011</last_update_submitted>
  <last_update_submitted_qc>July 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. Amie Cullimore</name_title>
    <organization>Faculty of Health Sciences, McMaster University</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rupture</mesh_term>
    <mesh_term>Fetal Membranes, Premature Rupture</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

